Cargando…
Biomarker Discovery for Immunotherapy of Pituitary Adenomas: Enhanced Robustness and Prediction Ability by Modern Computational Tools
Pituitary adenoma (PA) is prevalent in the general population. Due to its severe complications and aggressive infiltration into the surrounding brain structure, the effective management of PA is required. Till now, no drug has been approved for treating non-functional PA, and the removal of cancerou...
Autores principales: | Yang, Qingxia, Wang, Yunxia, Zhang, Song, Tang, Jing, Li, Fengcheng, Yin, Jiayi, Li, Yi, Fu, Jianbo, Li, Bo, Luo, Yongchao, Xue, Weiwei, Zhu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6337483/ https://www.ncbi.nlm.nih.gov/pubmed/30609812 http://dx.doi.org/10.3390/ijms20010151 |
Ejemplares similares
-
The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
por: Dai, Congxin, et al.
Publicado: (2020) -
Research advances on the immune research and prospect of immunotherapy in pituitary adenomas
por: Nie, Ding, et al.
Publicado: (2021) -
The utility of dynamic MRI in differentiating the hormone-producing ability of pituitary adenomas
por: Amano, Taishi, et al.
Publicado: (2021) -
Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
por: Netuka, David, et al.
Publicado: (2022) -
Discovery of the Consistently Well-Performed Analysis Chain for SWATH-MS Based Pharmacoproteomic Quantification
por: Fu, Jianbo, et al.
Publicado: (2018)